FLT3 pathway is a potential therapeutic target for PRC2-mutated T-cell acute lymphoblastic leukemia.
Zhang J, Zhang Y, Zhang M, Liu C, Liu X, Yin J, Wu P, Chen X, Yang W, Zhang L, Guo Y, Zou Y, Chen Y, Cao Y, Cheng T, Zhu X.
Zhang J, et al. Among authors: guo y.
Blood. 2018 Dec 6;132(23):2520-2524. doi: 10.1182/blood-2018-04-845628. Epub 2018 Oct 3.
Blood. 2018.
PMID: 30282797
Free article.
No abstract available.